PROBENECID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Probenecid, and what generic alternatives are available?
Probenecid is a drug marketed by Aurobindo Pharma Usa, Ivax Sub Teva Pharms, Lederle, Rising, Watson Labs, Watson Labs Teva, Ani Pharms, Beecham, Impax Labs, Novast Labs, and Sandoz. and is included in fourteen NDAs.
The generic ingredient in PROBENECID is colchicine; probenecid. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
Summary for PROBENECID
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 14 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Clinical Trials: | 67 |
Patent Applications: | 2,589 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PROBENECID |
DailyMed Link: | PROBENECID at DailyMed |
Recent Clinical Trials for PROBENECID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Miami | Phase 3 |
United States Department of Defense | Phase 3 |
Haisco Pharmaceutical Group Co., Ltd. | Phase 1 |